HALEIGH THARP: Open Payments
NPI 1043094279 · GREENWOOD, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,310 in 141 payments from 20 companies in 2025. Trend: 2023 $0 · 2024 $1,068 · 2025 $2,310
Food & beverage: $2,310
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $290 |
| Novo Nordisk Inc | 25 | $270 |
| AstraZeneca Pharmaceuticals LP | 11 | $249 |
| Lilly USA, LLC | 16 | $244 |
| PFIZER INC. | 14 | $197 |
| Otsuka America Pharmaceutical, Inc. | 7 | $159 |
| ABBVIE INC. | 13 | $155 |
| Collegium Pharmaceutical, Inc. | 7 | $150 |
| Axsome Therapeutics, Inc. | 7 | $130 |
| MAYNE PHARMA COMMERCIAL LLC | 8 | $91 |
Products named: CAPLYTA, MOUNJARO, Ozempic, REXULTI, NURTEC ODT, Jornay PM, Auvelity, AIRSUPRA.
Industry payments across IN — which companies pay providers there.
